Korean Circ J.
2009 Feb;39(2):75-78. 10.4070/kcj.2009.39.2.75.
Abciximab (ReoPro)-Induced Thrombocytopenia Diagnosed Through Measurement of Heparin-Dependent Antibody
- Affiliations
-
- 1Division of Cardiology, Department of Internal Medicine, Dong-A University College of Medicine, Busan, Korea. thpark65@dau.ac.kr
- KMID: 2297953
- DOI: http://doi.org/10.4070/kcj.2009.39.2.75
Abstract
- Abciximab (ReoPro) is an extremely potent inhibitor of the glycoprotein IIb/IIIa receptor. Its main application is in the maintenance of coronary flow after suboptimal coronary intervention. Complications associated with this drug include bleeding and severe thrombocytopenia. We report a case of severe thrombocytopenia secondary to abciximab therapy for percutaneous coronary intervention in a 65-year-old woman suffering from an acute myocardial infarction. Her platelet count dropped to 1,000/mm3 7 hours after abciximab administration and improved with transfusion of 12 units of platelet concentrate the following day. The patient was diagnosed through measurement of heparin-dependent antibodies and readministration of heparin.
Keyword
MeSH Terms
-
Aged
Antibodies
Antibodies, Monoclonal
Blood Platelets
Female
Glycoproteins
Hemorrhage
Heparin
Humans
Immunoglobulin Fab Fragments
Myocardial Infarction
Percutaneous Coronary Intervention
Platelet Count
Stress, Psychological
Thrombocytopenia
Antibodies
Antibodies, Monoclonal
Glycoproteins
Heparin
Immunoglobulin Fab Fragments
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Two Cases of Heparin-Induced Thrombocytopenia Diagnosed by Particle Gel Immunoassay
- Cardiopulmonary Bypass in Patient with Heparin-Induced Thrombocytopenia Employing Recombinant Hirudin
- Heparin-induced Thrombocytopenia Type II after Free Flap Operation
- A case of acute profound thrombocytopenia following abciximab therapy
- Two Cases of Heparin-Induced Thrombocytopenia in Hemodialysis Patients
